Report Finds Radiotherapy of Questionable Benefit for Sarcomatoid Mesothelioma, According to Surviving Mesothelioma

Share Article

A new study suggests that more research is needed to determine whether radiation can improve mesothelioma survival after surgery.

Radiation Therapy for Mesothelioma Survival

Post-Surgical Radiotherapy for Mesothelioma

Evidence from this analysis is insufficient on its own to routinely recommend postoperative radiotherapy...

An Egyptian doctor says radiation therapy may not provide a survival benefit for all mesothelioma patients. Surviving Mesothelioma has just posted an article on the new research. Click here to read it now.

An analysis of more than 2,000 mesothelioma cases over a ten-year period found that radiotherapy after surgery had limited benefits for people with the sarcomatoid subtype of malignant mesothelioma.

“Evidence from this analysis is insufficient on its own to routinely recommend postoperative radiotherapy for surgically resected malignant pleural mesothelioma,” concludes the report, which calls for “large-scale prospective clinical trials” of radiotherapy for mesothelioma.

The study, published in the German medical journal Strahlenther Onkologie, utilized mesothelioma survival data from the Surveillance, Epidemiology, and End Results (SEER) database between 2000 and 2013.

“We know that patients who undergo multi-modal mesothelioma therapy live longer, but the question is always which therapies will be most effective for which patients,” says Alex Strauss. “This study helps answer that question for a subset of mesothelioma patients.”

For additional details about the impact of post-surgical radiation on mesothelioma survival, see The Role of Post-Surgical Radiation in Mesothelioma Survival, now available on the Surviving Mesothelioma website.

Abdel-Rahman, O, “Role of postoperative radiotherapy in the management of malignant pleural mesothelioma: A propensity score matching of the SEER database”, January 2, 2017, Strahlenther Onkologie, Epub ahead of print, https://www.ncbi.nlm.nih.gov/pubmed/28044200

For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michael Ellis
Cancer Monthy
+1 (919) 570-8595
Email >
Follow us on
Visit website